ZA8803492B - Flunarizine-containing compositions - Google Patents

Flunarizine-containing compositions

Info

Publication number
ZA8803492B
ZA8803492B ZA883492A ZA8803492A ZA8803492B ZA 8803492 B ZA8803492 B ZA 8803492B ZA 883492 A ZA883492 A ZA 883492A ZA 8803492 A ZA8803492 A ZA 8803492A ZA 8803492 B ZA8803492 B ZA 8803492B
Authority
ZA
South Africa
Prior art keywords
flunarizine
compositions
Prior art date
Application number
ZA883492A
Inventor
Jean Mesens
Mesens Jean
Achiel Paul Van Peer
Paul Van Peer Achiel
Josef Jan Pieter Heykants
Jan Pieter Heykants Josef
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5064487A priority Critical
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA8803492B publication Critical patent/ZA8803492B/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
ZA883492A 1987-05-18 1988-05-17 Flunarizine-containing compositions ZA8803492B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US5064487A true 1987-05-18 1987-05-18

Publications (1)

Publication Number Publication Date
ZA8803492B true ZA8803492B (en) 1990-01-31

Family

ID=21966482

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA883492A ZA8803492B (en) 1987-05-18 1988-05-17 Flunarizine-containing compositions
ZA883492A ZA883492B (en) 1987-05-18 1988-05-17 Flunarizine-containing compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA883492A ZA883492B (en) 1987-05-18 1988-05-17 Flunarizine-containing compositions

Country Status (19)

Country Link
EP (1) EP0292050B1 (en)
JP (1) JPS63303926A (en)
KR (1) KR880013559A (en)
AT (1) AT69555T (en)
AU (1) AU603895B2 (en)
DE (1) DE3866281D1 (en)
DK (1) DK268788A (en)
ES (1) ES2051827T3 (en)
FI (1) FI882307A (en)
GR (1) GR3003482T3 (en)
HU (1) HU199073B (en)
IE (1) IE60937B1 (en)
IL (1) IL86395A (en)
NO (1) NO882134L (en)
NZ (1) NZ224497A (en)
PH (1) PH24425A (en)
PT (1) PT87496B (en)
RU (1) RU1829935C (en)
ZA (2) ZA8803492B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532002A (en) * 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
ES2062543T3 (en) * 1989-08-17 1994-12-16 Cortecs Ltd pharmaceutical formulations.
WO1994012198A1 (en) * 1992-11-27 1994-06-09 F.H. Faulding & Co. Limited Injectable taxol composition
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
FR2729307B1 (en) * 1995-01-18 1997-04-18 Seppic Sa Use of ethoxyl fatty acid esters as self-emulsionable components especially useful for the preparation of phytosanitary treatment products or medicinal products for veterinary or human use
WO1999024475A1 (en) * 1997-11-07 1999-05-20 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
ES2338538T3 (en) * 2001-09-10 2010-05-10 Tibotec Pharmaceuticals METHOD FOR THE PREPARATION OF HEXAHYDROFIDE (2,3-B) FURAN-3-OL.
AR038681A1 (en) * 2002-02-14 2005-01-26 Solvay Pharm Bv ORAL FORMULATION OF SOLID SOLUTION OF A POVERLY SOLUBLE ACTIVE SUBSTANCE IN WATER
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
JP5951489B2 (en) 2009-10-16 2016-07-13 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC Composition
CN104069086A (en) * 2014-07-22 2014-10-01 周有财 Flunarizine hydrochloride composition capsule and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica Nv PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
DE3587978D1 (en) * 1984-01-28 1995-02-23 Roshdy Ismail Agents for the treatment of diseases of the veins and the anal area.
DE3421468A1 (en) * 1984-06-08 1985-12-19 Rentschler Arzneimittel LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5047229A (en) * 1986-12-17 1991-09-10 Miles, Inc. Treatment of cardiovascular and cerebral toxicity using calcium modulators

Also Published As

Publication number Publication date
FI882307A0 (en) 1988-05-17
HUT46851A (en) 1988-12-28
FI882307D0 (en)
NZ224497A (en) 1990-04-26
NO882134D0 (en) 1988-05-16
GR3003482T3 (en) 1993-02-17
KR880013559A (en) 1988-12-21
JPS63303926A (en) 1988-12-12
PT87496A (en) 1989-05-31
ZA883492B (en) 1990-01-31
AU1613288A (en) 1988-11-24
EP0292050B1 (en) 1991-11-21
PT87496B (en) 1992-09-30
AT69555T (en) 1991-12-15
RU1829935C (en) 1993-07-23
IL86395A (en) 1992-11-15
IL86395D0 (en) 1988-11-15
PH24425A (en) 1990-06-25
DE3866281D1 (en) 1992-01-02
NO882134L (en) 1988-11-21
AU603895B2 (en) 1990-11-29
EP0292050A1 (en) 1988-11-23
FI882307A (en) 1988-11-19
HU199073B (en) 1990-01-29
DK268788D0 (en) 1988-05-17
DK268788A (en) 1988-11-19
ES2051827T3 (en) 1994-07-01
IE60937B1 (en) 1994-09-07
IE881477L (en) 1988-11-18

Similar Documents

Publication Publication Date Title
EP0293885A3 (en) Antibiotic-polymer compositions
JPS63235387A (en) Tixotropic composition
JPS63289059A (en) Composition
GB8721936D0 (en) Composition
GB8827331D0 (en) Compositions
GB8716949D0 (en) Composition
EP0301332A3 (en) Positive-photoresist compositions
JPS63246302A (en) Lousicidal composition
GB2203336B (en) Composition
EP0292963A3 (en) Fiber-treatment composition
GB8709896D0 (en) Composition
HUT51856A (en) Mollusquicid composition
ZA8803492B (en) Flunarizine-containing compositions
GB8715191D0 (en) Composition
EG18594A (en) Shampo composition
GB8702613D0 (en) Compositions
JPS63196515A (en) Coccidiocidal composition
GB8718886D0 (en) Composition
GB8716338D0 (en) Anti-anxiogenic compositions
GB8700466D0 (en) Teat-treating compositions
IE870643L (en) Selant compositions
JPS63230752A (en) Butene-1-polymer composition
GB8713513D0 (en) Fibre-polymer compositions
IE870402L (en) Antiviral-antitumor compositions
GB8714902D0 (en) Compositions